PGM1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA024190

Antibody HPA024637

Antibody HPA046329

Antibody CAB004666

Tissue

Antibody staining

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignant tissues were negative. A few cases of hepatocellular and renal cancers showed moderate cytoplasmic and nuclear staining.Malignancies in liver, breast and kidney showed weak to moderate cytoplasmic immunoreactivity. Remaining malignant cells were weakly stained or negative.Moderate to strong cytoplasmic and nuclear positivity was observed in several hepatocellular carcinomas. Renal and prostate cancers along with a few adenocarcinomas of lung, papillary adenocarcinomas of thyroid, ovarian and endometrial cancers showed weak to moderate cytoplasmic immunoreactivity. Remaining cancer tissues were generally negative.Liver, renal, skin and prostate cancers showed showed moderate to strong cytoplasmic positivity. Remaining malignancies were weakly stained or negative.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataConsistent with gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected